Published ahead of print on October 26, 2006, doi:10.1164/rccm.200606-851OC
© 2007 American Thoracic Society doi: 10.1164/rccm.200606-851OC
Endoscopic Ultrasound As a First Test for Diagnosis and Staging of Lung CancerA Prospective Study1 Division of Gastroenterology, Central Texas Veterans Health Care System, Temple, Texas; 2 Department of Surgery, Henderson Memorial Hospital, Henderson, Texas; 3 Department of Radiology, Central Texas Veterans Health Care System, Temple, Texas; 4 Division of Oncology, Central Texas Veterans Health Care System, Temple, Texas; 5 Department of Internal Medicine, Central Texas Veterans Health Care System, Temple, Texas; 6 Department of Biostatistics & Epidemiology, School of Rural & Public Health, Texas A&M University, College Station, Texas; 7 Department of Biostatistics, City of Hope National Medical Center, Duarte, California; 8 Division of Gastroenterology, VA Boston Healthcare System, Boston, Massachusetts; 9 Division of Pulmonary & Critical Care, Central Texas Veterans Health Care System, Temple, Texas; and 10 Division of Gastroenterology & Hepatology, Scott & White Memorial Hospital, Temple, Texas Correspondence and requests for reprints should be addressed to Pankaj Singh, M.D., M.S., Central Texas Veterans Health Care System, 1901 South 1st Street, Temple, TX 76504. E-mail: pankaj1110{at}hotmail.com Rationale: Multiple tests are required for the management of lung cancer. Objectives: Endoscopic ultrasoundguided fine needle aspiration (EUS-FNA) was evaluated as a single test for the diagnosis and staging (thoracic and extrathoracic) of lung cancer. Methods: Consecutive subjects with computed tomography (CT) findings of a lung mass were enrolled for EUS and results were compared with those from CT and positron emission tomography scans. Results: Of 113 subjects with lung cancer, EUS was performed as a first test (after CT scan) for diagnosis in 93 (82%) of them. EUS-FNA established tissue diagnosis in 70% of cases. EUS-FNA, CT, and positron emission tomography detected metastases to the mediastinal lymph nodes with accuracies of 93, 81, and 83%, respectively. EUS-FNA was significantly better than CT at detecting distant metastases (accuracies of 97 and 89%, respectively; p = 0.02). Metastases to lymph nodes at the celiac axis (CLNs) were observed in 11% of cases. The diagnostic yields of EUS-FNA and CT for detection of metastases to the CLNs were 100 and 50%, respectively (p < 0.05). EUS was able to detect small metastases (less than 1 cm) often missed by CT. Metastasis to the CLNs was a predictor of poor survival of subjects with nonsmall cell lung cancer, irrespective of the size of the CLNs. Of 44 cases with resectable tumor on CT scan, EUS-FNA avoided thoracotomy in 14% of cases. Conclusions: EUS-FNA as a first test (after CT) has high diagnostic yield and accuracy for detecting lung cancer metastases to the mediastinum and distant sites. Metastasis to the CLNs is associated with poor prognosis. EUS-FNA is able to detect occult metastasis to the CLNs and thus avoids thoracotomy.
Key Words: lung cancer nonsmall cell lung cancer celiac lymph nodes endoscopic ultrasoundguided fine needle aspiration survival
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||